CytoDyn (STU:296) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:296 CytoDyn Inc STU:296
31 GF Score
Price €0.18
! 1 Warning Sign
View Full Analysis

What is CytoDyn Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

STU:296
31GF Score
CytoDyn Inc STU:296
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CytoDyn Business Description

Other Exchanges CYDY:USA
Address 1111 Main Street, Suite 660, Vancouver, WA, USA, 98660
CytoDyn Inc. is a clinical-stage biotechnology company based in the United States. Its principal product candidate is leronlimab, a humanized monoclonal antibody that targets the CCR5 receptor. The company has pursued development of leronlimab across multiple therapeutic areas, including HIV, cancer, and inflammatory conditions, though it has not received regulatory approval for commercial sale. CytoDyn operates as a single reporting segment centered on the clinical development of leronlimab. As a pre-revenue company, it has historically funded operations through equity and debt financings and partnership arrangements rather than product sales. Its activities are concentrated in the United States, where it conducts research and clinical trials, and it has no established commercial product portfolio or significant recurring revenue stream.
31GF Score

Get the complete analysis for STU:296

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price